key: cord-0784912-ucx3ncx7
authors: Wang, Ruo Ran; He, Min; Kang, Yan
title: A risk score based on procalcitonin for predicting acute kidney injury in COVID‐19 patients
date: 2021-05-25
journal: J Clin Lab Anal
DOI: 10.1002/jcla.23805
sha: 981851bf081eb621e0f9add55477b2784950be10
doc_id: 784912
cord_uid: ucx3ncx7

BACKGROUND: Acute kidney injury (AKI) has been reported developing commonly in coronavirus disease 2019 (COVID‐19) patients and could increase the risk of poor outcomes in these patients. We design this study to explore the value of serum procalcitonin (PCT) on predicting AKI and construct risk score for predicting AKI in COVID‐19 patients. METHODS: Patients diagnosed with COVID‐19 and hospitalized in Renmin Hospital of Wuhan University between January 30 and February 24, 2020, were included. The least absolute shrinkage and selection operator (LASSO) regression was performed to identify the strongest predictors of AKI. Multivariate logistic regression analysis was conducted to find independent risk factors for AKI and construct risk score using odds ratio (OR) value of those risk factors. Receiver operating characteristics (ROC) curves were plotted, and area under the ROC curve (AUC) value was calculated to evaluate the predictive value of single PCT level and the constructed risk score. RESULTS: Among 389 included COVID‐19 patients, 28 (7.2%) patients developed AKI. LASSO regression showed hypertension, saturation of arterial oxygen (SaO(2)), PCT, and blood urea nitrogen (BUN) were the strongest predictors for AKI. After multivariate logistic regression analysis, only SaO(2) (<0.001), PCT (p = 0.004), and BUN (p = 0.005) were independently associated with development of AKI in COVID‐19 patients. The AUC of single PCT and constructed risk score was 0. 881 and 0.928, respectively. CONCLUSION: PCT level is correlated with AKI in COVID‐19 patients. The efficient risk score consisted of SaO(2), PCT, and BUN is readily accessible for physicians to evaluate the possibility of AKI in COVID‐19 patients.

storm developed in COVID-19 patients, which indicates excessively upregulated production of cytokines, could result in the systemic inflammatory response (SIRS) and subsequent multiorgan dysfunction syndrome (MODS). 1, 2 In addition to the prominent respiratory failure, other organ dysfunction including liver injury, cardiac injury, and kidney injury were also commonly developed in COVID-19 patients. [3] [4] [5] [6] Moreover, the development of extra-pulmonary organ injuries has been confirmed associated with higher mortality of COVID-19 patients. [7] [8] [9] [10] Acute kidney injury (AKI), whose incidence ranged from 0.5% to 40% in COVID-19 patients, could increase the risk of poor outcome and length of hospital stay. 6, [11] [12] [13] [14] Consequently, identifying COVID-19 patients with high risk of developing AKI during hospitalization and therefore making suitable treatment strategies are essential to improve prognosis of patients.

The procalcitonin (PCT), a precursor of the calcitonin under physiological condition, could be increasingly produced under pathological inflammatory stimulation and is discovered associated with severity of SIRS. 15, 16 Previous studies have found that serum PCT level was useful in predicting the development of AKI during hospitalization for many kinds of diseases including critically ill, traumatic injury, influenza infection, and acute pancreatitis. [17] [18] [19] [20] [21] However, the specific association between PCT and AKI in COVID-19 patients has not been explored. We designed this study to evaluate the value of PCT on predicting AKI in COVID-19 patients. Furthermore, we constructed a multivariate risk score to grade the risk level of developing AKI in COVID-19 patients.

Patients admitted to Renmin Hospital of Wuhan University for COVID-19 from January 30 to February 24, 2020, were eligible for this study. The diagnosis of COVID-19 was confirmed by positive results of COVID-19 RNA in nasopharyngeal swabs utilizing realtime fluorescence reverse transcription-polymerase chain reaction (RT-PCR). Patients transferred from other hospitals and those who lacked clinical or laboratory records were excluded from this study.

We collected relevant clinical and laboratory variables from electronic medical record (EMR) system of Renmin Hospital of Wuhan University. Demographic variables (age, sex) and vital signs on admission (mean blood pressure, heart rate, body temperature and respiratory rate, saturation of oxygen) were collected in this study. History of underlying diseases including hypertension, chronic obstructive pulmonary disease (COPD), cardiovascular disease, diabetes mellitus, liver disease, and malignancy were also collected. Variables of blood routine and blood biochemistry tests including serum PCT level were obtained by analyzing blood samples collected at admission. 

Kolmogorov-Smirnov test was utilized to confirm the normality of included variables. Normally distributed variables were presented as mean ±standard deviation while non-normally distributed variables were presented as median (interquartile range). And categorical variables were shown as counts (percentage). We performed Student's t test and Mann-Whitney U test to compare the difference between two groups of normally distributed variables and two groups of non-normally distributed variables, respectively. Chi-square test or

Fisher's exact test were conducted to testify the difference between two groups of categorical variables. The least absolute shrinkage and selection operator (LASSO) regression, which could minimize the collinearity of selected risk factors and avoid overfitting of these factors, was performed to identify predictors with nonzero coefficients. Identifying the strongest predictors from plenty of potential risk factors for targeted outcome with relatively small quantity is another advantage of LASSO regression. Predictors with nonzero coefficients were then included in multivariate logistic regression analysis to explore independent risk factors and construct risk score for predicting AKI in COVID-19 patients. Odds ratio (OR) and 95% confidence intervals (CI) of each risk factors were calculated and presented. The risk score was constructed based on the OR value of each independent risk factor. Receiver operating characteristic (ROC) curves of single predictors and constructed risk score were drawn, and area under the ROC curve (AUC) value of them was calculated. Z test was conducted to verify the difference of AUC between single serum PCT level and the constructed risk score.

Two-sided P value <0.05 was considered statistically significant. 

A total of 389 patients confirmed with COVID-19 were included in this study. Among them, 28 patients developed AKI during their hospitalization with an incidence of 7.8% (Table 1) . We divided patients into two groups according to the occurrence of AKI and then TA B L E 1 Baseline characteristics of included COVID-19 patients grouped by the development of AKI 

SaO 2 , PCT, and BUN were transformed into binary variables based on their corresponding cutoff value, Then, SaO 2 , PCT, and BUN remained independent risk factors for AKI in multivariate logistic regression analysis and OR of these three variables are shown in Table 3 . Corresponding scores of these three factors were assigned according to their β coefficients. Presented as Table 4 , the risk score was readily used in clinical practice, which ranged from 0 to 3. The 

AKI is a kind of common organ dysfunction which has been observed occurring in 8.4% to 19.6% hospitalized patients. 22 hypertension and cardiovascular disease than non-AKI group. The fact that mortality of AKI group was higher than that of non-AKI group also indicated AKI development was unfavorable to outcome of COVID-19 patients and suitable treatment decisions should be taken to avoid this detrimental complication.

The mechanism involved in the development of AKI in COVID-19

patients may be multifactorial. Bioinformatic analyses indicated that angiotensin-converting enzyme 2 (ACE2), which is acknowledged as a major receptor of SARS-CoV-2, is highly expressed in renal tissue. 25 Previous studies have confirmed that proinflammatory cytokines, especially the IL-6, play a key role in the pathophysiological process of AKI. [32] [33] [34] Besides, other common risk factors during viral infection including hypotension, hypoxemia, thrombosis, rhabdomyolysis, and unsuitable use of nephrotoxic drugs may also collectively aggravate the abnormal renal function. 28, 35, 36 In this study, multivariate logistic regression analysis showed that SaO 2 , PCT, and BUN were three independent risk factors for AKI in COVID-19 patients. The hypoxemia, which sometimes be defined as SaO 2 <90%, has been verified associated with deteriorating renal function. 37, 38 A recent study showed COVID-19 patients with AKI whose renal function improved had higher oxygenation index than those did not improved. Therefore, it is logical and effective to include SaO 2 into our constructed risk score. Another constituent in our risk score is PCT, which has been confirmed as a reliable maker for predicting AKI in many kinds of patients including those diagnosed with critically ill, traumatic injury, influenza infection or acute pancreatitis. 17 

Patients's percentage of AKI grouped by constructed risk score. The incidence of AKI in low-risk group, medium-risk group and high-risk group was 0.71% (2/282), 9.46% (7/74) and 57.58% (19/33), respectively records of PCT level on admission were excluded from this study so that the selection bias could not be avoided. Secondly, urine volume, an important indicator for diagnosis of AKI, was not recorded in our study. This is partly due to the lack of records of urine volume in mildly and moderately ill patients. Thirdly, the detailed extent of lung involvement was not recorded by us which may affect the severity of kidney injury. Finally, we did not divide overall enrolled patients into training set and validation set due to the limited number of AKI event. Further study with larger sample size could be conducted in other medical centers to verify the value of our risk score.

Single PCT value is a valuable predictive marker of AKI in COVID-19

patients, the risk score we constructed using serum PCT level could readily and efficiently help clinicians evaluate the possibility of developing AKI in COVID-19 patients.

All authors declare no conflict of interest.

Ruoran Wang was involved in the data analysis, and drafting of the manuscript. Min He was involved in the data collection and interpretation of the results. Yan Kang interpreted the results and contributed to the reviewing of the draft.

The data used and analyzed during this study are available from the corresponding author on reasonable request.

Yan Kang https://orcid.org/0000-0002-5715-3900

Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection

Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets

Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan

COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients

Acute kidney injury associated with COVID-19: A retrospective cohort study

The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan

Liver damage at admission is an independent prognostic factor for COVID-19

The indicative role of markers for liver injury on the severity and prognosis of coronavirus disease 2019 patients

Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review

Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York

Clinical characteristics of coronavirus disease 2019 in China

High burden of acute kidney injury in COVID-19 pandemic: systematic review and meta-analysis

Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and metaanalysis

Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro

Significance of serum procalcitonin levels in the evaluation of severity and prognosis of patients with systemic inflammatory response syndrome

Independent predictive ability of procalcitonin of acute kidney injury among critically Ill patients

Serum procalcitonin level predicts acute kidney injury after traumatic brain injury

Association between acute kidney injury and serum procalcitonin levels and their diagnostic usefulness in critically ill patients

Relationship between acute kidney injury and serum procalcitonin (PCT) concentration in critically ill patients with influenza infection

Procalcitonin levels predict acute kidney injury and prognosis in acute pancreatitis: a prospective study

Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study

Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based casecontrol study

Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study

Bioinformatic characterization of angiotensinconverting enzyme 2, the entry receptor for SARS-CoV-2

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Ultrastructural evidence for direct renal infection with SARS-CoV-2

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors

SARS-CoV-2 infection: the role of cytokines in COVID-19 disease

IL-6/IL-6R axis plays a critical role in acute kidney injury

Impact of sepsisassociated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis

Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis

Renal involvement and early prognosis in patients with COVID-19 pneumonia

Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology

A cause of acute renal failure and alteration of gastrointestinal microbial ecology

Mechanisms of hypoxia responses in renal tissue

Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study

Expression and secretion of procalcitonin and calcitonin generelated peptide by adherent monocytes and by macrophageactivated adipocytes

Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury

Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis

Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs

A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients